Joy A. Nishime

828 total citations
14 papers, 690 citations indexed

About

Joy A. Nishime is a scholar working on Pharmacology, Infectious Diseases and Oncology. According to data from OpenAlex, Joy A. Nishime has authored 14 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 9 papers in Infectious Diseases and 6 papers in Oncology. Recurrent topics in Joy A. Nishime's work include Pharmacogenetics and Drug Metabolism (12 papers), HIV/AIDS drug development and treatment (9 papers) and Drug Transport and Resistance Mechanisms (6 papers). Joy A. Nishime is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), HIV/AIDS drug development and treatment (9 papers) and Drug Transport and Resistance Mechanisms (6 papers). Joy A. Nishime collaborates with scholars based in United States. Joy A. Nishime's co-authors include Masato Chiba, Jiunn H. Lin, Suresh K. Balani, J H Lin, Masayo Yamazaki, Kari Vastag, Jerome Hochman, J H Lin, Gloria Y. Kwei and I‐Wu Chen and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Joy A. Nishime

14 papers receiving 667 citations

Peers

Joy A. Nishime
Heike Tegude Germany
Michael Kukulka United States
J H Lin United States
Lisa M. Almond United Kingdom
Bryan A. Ward United States
A J Wood United States
Grant T. Generaux United States
Gary D. Bowers United States
Scott D. Studenberg United States
Heike Tegude Germany
Joy A. Nishime
Citations per year, relative to Joy A. Nishime Joy A. Nishime (= 1×) peers Heike Tegude

Countries citing papers authored by Joy A. Nishime

Since Specialization
Citations

This map shows the geographic impact of Joy A. Nishime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy A. Nishime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy A. Nishime more than expected).

Fields of papers citing papers by Joy A. Nishime

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy A. Nishime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy A. Nishime. The network helps show where Joy A. Nishime may publish in the future.

Co-authorship network of co-authors of Joy A. Nishime

This figure shows the co-authorship network connecting the top 25 collaborators of Joy A. Nishime. A scholar is included among the top collaborators of Joy A. Nishime based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy A. Nishime. Joy A. Nishime is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hochman, Jerome, Masato Chiba, Joy A. Nishime, Masayo Yamazaki, & J H Lin. (2000). Influence of P-Glycoprotein on the Transport and Metabolism of Indinavir in Caco-2 Cells Expressing Cytochrome P-450 3A4. Journal of Pharmacology and Experimental Therapeutics. 292(1). 310–318. 103 indexed citations
2.
Chiba, Masato, Joy A. Nishime, William Neway, Yun‐Lian Lin, & J H Lin. (2000). Comparativein vitrometabolism of indinavir in primates - a unique stereoselective hydroxylation in monkey. Xenobiotica. 30(2). 117–129. 10 indexed citations
3.
Lin, Jiunn H., I‐Wu Chen, Masato Chiba, Joy A. Nishime, & F A deLuna. (2000). Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation. Drug Metabolism and Disposition. 28(4). 460–466. 11 indexed citations
5.
Lin, Jiunn H., Masato Chiba, I‐Wu Chen, et al.. (1999). Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction. Drug Metabolism and Disposition. 27(10). 1187–1193. 34 indexed citations
6.
Nishime, Joy A., Regina W. Wang, J H Lin, & Masato Chiba. (1999). Modulation of Rat Cytochrome P-450 by an Investigational HIV Protease Inhibitor. Drug Metabolism and Disposition. 27(9). 972–976. 2 indexed citations
7.
Lin, Jiunn H., Masato Chiba, I‐Wu Chen, et al.. (1999). Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .. PubMed. 27(10). 1187–93. 73 indexed citations
8.
Chiba, Masato, Joy A. Nishime, I‐Wu Chen, et al.. (1998). Metabolite–P450 Complex Formation by Methylenedioxyphenyl HIV Protease Inhibitors in Rat and Human Liver Microsomes. Biochemical Pharmacology. 56(2). 223–230. 8 indexed citations
9.
Chiba, Masato, Xin Xu, Joy A. Nishime, Suresh K. Balani, & Jiunn H. Lin. (1997). Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans.. PubMed. 25(9). 1022–31. 77 indexed citations
10.
Lin, Jiunn H., et al.. (1996). Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.. Drug Metabolism and Disposition. 24(12). 1298–1306. 44 indexed citations
11.
Chiba, Masato, et al.. (1996). Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.. Drug Metabolism and Disposition. 24(3). 307–314. 118 indexed citations
12.
Lin, Jiunn H., Masato Chiba, Suresh K. Balani, et al.. (1996). Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.. Drug Metabolism and Disposition. 24(10). 1111–1120. 130 indexed citations
13.
Chiba, Masato, Joy A. Nishime, & J H Lin. (1995). Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 275(3). 1527–1534. 49 indexed citations
14.
Lin, Jiunn H., Masato Chiba, Kari Vastag, et al.. (1995). Time- and dose-dependent pharmacokinetics of L-754,394, an HIV protease inhibitor, in rats, dogs and monkeys.. Journal of Pharmacology and Experimental Therapeutics. 274(1). 264–269. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026